← Browse by Condition
Medical Condition

autoimmune polyendocrinopathy candidiasis ectodermal dystrophy apeced

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05398809 Phase 2
Recruiting

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

Enrollment
70 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →